Jonathan Dawley Takes Over As President & CEO Of Kion North America

By RTTNews Staff Writer ✉ | Published: 5/18/2020 10:52 AM ET

Kion Group (KGX.DE) said that Jonathan Dawley took over as President & CEO of KION North America today. He succeeds Vincent Halma, who has left the KION Group.

Jonathan Dawley joins the KION Group from Putzmeister Holding GmbH, a subsidiary of Sany Heavy Industry Corporation, where he was head of the Americas region for over two years.

Between 2014 and 2018, he was responsible for the global aftermarket business at JLG Industries Corporation, a subsidiary of Oshkosh Corporation. He gained extensive experience in intralogistics as well as in the material handling business in various senior management roles at Hyster-Yale Materials Handling from 2005 to 2014.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In June 2020

Countries that tamed coronavirus

The 1918 Spanish Flu Pandemic

Editors Pick

Latam Airlines Files For Bankruptcy Protection In New York

Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,...

Pizza Hut Offers Half A Million Free Pizzas To 2020 Graduates

Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4.

Merck Inks Deals, Joins Coronavirus Vaccine Race

Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.